Clinical Trials Directory

Trials / Completed

CompletedNCT01577433

Driveline Silicone Skin Interface Registry

Driveline Silicone Skin Interface (SSI) Registry

Status
Completed
Phase
Study type
Observational
Enrollment
400 (actual)
Sponsor
Abbott Medical Devices · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this observational registry is to determine the freedom from driveline (DL) infection events in subjects implanted with a HeartMate II LVAD in whom only the silicone portion of the DL is externalized resulting in a silicone skin interface (SSI)

Conditions

Timeline

Start date
2012-05-01
Primary completion
2018-07-01
Completion
2018-12-01
First posted
2012-04-13
Last updated
2019-03-13

Locations

15 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01577433. Inclusion in this directory is not an endorsement.